Concepedia

Betty Razvillas

BR

5

Publications

380

Citations

5

H-Index

1997

Active since

Affiliations

The University of Texas Health Science Center at San Antonio(Current)

Dana-Farber Cancer Institute

Betty Razvillas is an author at The University of Texas Health Science Center at San Antonio specializing in medicine, oncology, and pharmacotherapy.

Top concepts

Publications per year

1997–2001

5

Publications

5

Phase I Study of Recombinant Human CD40 Ligand in Cancer Patients

Robert H. Vonderheide, Janice P. Dutcher, Jeanne E. Anderson et al. · Journal of Clinical Oncology · 2001 · 224 citations

Myeloablation and autologous peripheral blood stem cell rescue results in hematologic and clinical responses in patients with myeloid metaplasia with myelofibrosis

Jeanne E. Anderson, Ayalew Tefferi, Fiona E. Craig et al. · Blood · 2001 · 76 citations · Full text

Phase I and Pharmacokinetic Study of LU79553, a DNA Intercalating Bisnaphthalimide, in Patients With Solid Malignancies

Miguel A. Villalona‐Calero, Joseph P. Eder, Deborah Toppmeyer et al. · Journal of Clinical Oncology · 2001 · 37 citations

Phase I and pharmacokinetic study of the water-soluble dolastatin 15 analog LU103793 in patients with advanced solid malignancies.

Miguel A. Villalona‐Calero, Sharyn D. Baker, L. A. Hammond et al. · Journal of Clinical Oncology · 1998 · 32 citations

Phase II study of flutamide as second line chemotherapy in patients with advanced pancreatic cancer

Jivesh Sharma, Betty Razvillas, Connie Stephens et al. · Investigational New Drugs · 1997 · 11 citations

, , +9

Rows per page

1–5 of 5